These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 6838732

  • 21. Evaluation of intravenous amrinone: the first of a new class of positive inotropic agents with vasodilator properties.
    Bottorff MB, Rutledge DR, Pieper JA.
    Pharmacotherapy; 1985; 5(5):227-37. PubMed ID: 3906583
    [Abstract] [Full Text] [Related]

  • 22. Non-glycoside, non-catecholamine inotropic agents in the treatment of congestive heart failure.
    Tommaso CL.
    Am J Med; 1986 Feb 28; 80(2B):36-9. PubMed ID: 3004210
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Amrinone in the treatment of chronic cardiac failure.
    Likoff MJ, Weber KT, Andrews V, Janicki JS, Sutton MS, Wilson H, Rocci ML.
    J Am Coll Cardiol; 1984 May 28; 3(5):1282-90. PubMed ID: 6707381
    [Abstract] [Full Text] [Related]

  • 26. Chronic oral amrinone therapy in congestive heart failure: a double-blind placebo-controlled withdrawal study.
    Evans JR, Pacht K, Huss P, Unverferth DV, Bashore TM, Leier CV.
    Int J Clin Pharmacol Res; 1984 May 28; 4(1):9-18. PubMed ID: 6381344
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Amrinone-induced hepatotoxicity.
    Gilman ME, Margolis SC.
    Clin Pharm; 1984 May 28; 3(4):422-4. PubMed ID: 6467879
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Long-term amrinone therapy in patients with severe heart failure: drug-dependent hemodynamic benefits despite progression of disease.
    Maskin CS, Forman R, Klein NA, Sonnenblick EH, LeJemtel TH.
    Am J Med; 1982 Jan 28; 72(1):113-8. PubMed ID: 7058816
    [Abstract] [Full Text] [Related]

  • 32. Amrinone and exercise performance in patients with chronic heart failure.
    Weber KT, Andrews V, Janicki JS, Wilson JR, Fishman AP.
    Am J Cardiol; 1981 Jul 28; 48(1):164-9. PubMed ID: 7246438
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Amrinone therapy in patients with heart failure. Lack of improvement in functional capacity and left ventricular function at rest and during exercise.
    Johnston DL, Humen DP, Kostuk WJ.
    Chest; 1984 Sep 28; 86(3):394-400. PubMed ID: 6331987
    [Abstract] [Full Text] [Related]

  • 38. Acute pharmacodynamics and pharmacokinetics of oral amrinone.
    Benotti JR, Lesko LJ, McCue JE.
    J Clin Pharmacol; 1982 Oct 28; 22(10):425-32. PubMed ID: 7174852
    [Abstract] [Full Text] [Related]

  • 39. Hemodynamic effects of amrinone in dogs anesthetized with halothane: comparison with isoproterenol and dobutamine.
    Boncyk J, Redon D, Rusy B.
    Res Commun Chem Pathol Pharmacol; 1984 Jun 28; 44(3):347-54. PubMed ID: 6463363
    [Abstract] [Full Text] [Related]

  • 40. Hemodynamic effects of intravenous and oral amrinone in patients with severe heart failure: relationship between intravenous and oral administration.
    LeJemtel TH, Keung EC, Schwartz WJ, Maskin CS, Greenberg MA, Davis RS, Forman R, Ribner HS, Sonnenblick EH.
    Trans Assoc Am Physicians; 1979 Jun 28; 92():325-33. PubMed ID: 549256
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.